MarketPeel
Insider Trading Intelligence
YE

Yann Echelard

TGTX
DIRECTOR · TG THERAPEUTICS, INC. · CIK 0001561958
FILING MIX · LIFETIME67%/33%
BUYS
8
SELLS
4
TOTAL VALUE
$2.32M
COMPANIES
1
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
8,325
AVG SELL PX
$34.21
TRADE KIND
SHOWING 12 / 12
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 4 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Yann Echelard, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+40.00%+13.74%+1.79%+11.95%+16.03%
14d5+40.00%+11.52%+2.13%+9.39%+12.25%
30d5+40.00%+27.15%+4.62%+22.53%+24.93%
60d5+60.00%+15.20%+4.65%+10.54%+13.21%
90d5+60.00%+12.49%+5.75%+6.74%+5.11%
180d5+60.00%+31.23%+11.14%+22.27%+10.21%
1y5(1 pending)+50.00%+21.50%+23.77%-2.27%+10.92%
2y5(3 pending)+100.00%+38.64%+34.07%+4.57%+4.57%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
TGTX · 8,325 shares · as of Jun 11, 2026
061,025122,049183,074244,098202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 8 buys / 4 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
8,3258,325Jun 11, 2026Jun 15, 2026View →
TGTX
TG THERAPEUTICS, INC.
SALE
5,000$32.57$162.8K223,816Nov 24, 2025Nov 25, 2025View →
TGTX
TG THERAPEUTICS, INC.
SALE
10,000$36.94$369.4K228,816Jun 13, 2025Jun 16, 2025View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
14,718238,816Jun 12, 2025Jun 16, 2025View →
TGTX
TG THERAPEUTICS, INC.
SALE
20,000$24.48$489.6K224,098Nov 5, 2024Nov 7, 2024View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
22,250244,098Jun 19, 2024Jun 20, 2024View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,000221,848Sep 28, 2023Sep 29, 2023View →
TGTX
TG THERAPEUTICS, INC.
PURCHASE
9,000$10.64$95.8K201,848Jan 6, 2023Jan 6, 2023View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
43,732192,848Jul 20, 2022Jul 22, 2022View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
20,000149,116Jun 18, 2021Jun 22, 2021View →
TGTX
TG THERAPEUTICS, INC.
SALE
30,000$40.05$1.20M129,116Dec 10, 2020Dec 11, 2020View →
TGTX
TG THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
15,000159,116Jun 22, 2020Jun 24, 2020View →
Other insiders · TGTX
Loading peer insiders…
About this filer
CIK 0001561958
ROLE
Director
PRIMARY
TGTX
COMPANIES
1
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001561958DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback